Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06786403
PHASE3

The Effects of Bromelain Supplement in Patients with Diabetic Foot Ulcers

Sponsor: Dr Azita Hekmatdoost

View on ClinicalTrials.gov

Summary

This study will be conducted on people over 18 with diabetic foot ulcers.. The first group will receive the standard treatment along with bromelain supplement and the second group will receive the standard treatment and placebo. The informed consent form prepared in advance will also be provided to the patients so that they are fully familiar with the study process. Wound surface area, rate of pain, rate of inflammatory factors (ESR and CRP) will be assessed at baseline and every two weeks.

Official title: Investigating the Effectiveness of the Supplement Containing Enteric-coated Bromelain (Anaheal 1200 GDU) in Healing Wounds, Pain, and Inflammation in Patients Over 18 Years Old with Diabetic Foot Ulcers Compared to Placebo

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

70

Start Date

2025-03

Completion Date

2025-10

Last Updated

2025-01-22

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

Bromelain

Dietary Supplement: Bromelain 1000 mg/day

DIETARY_SUPPLEMENT

Placebo

Placebo (1000 mg/day)

Locations (1)

Iran

Tehran, Tehran Province, Iran